14 analysts have expressed a variety of opinions on Ecolab ECL over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 6 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 3 | 3 | 2 | 0 | 0 |
| 3M Ago | 2 | 1 | 1 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $271.5, a high estimate of $306.00, and a low estimate of $228.00. This upward trend is evident, with the current average reflecting a 5.55% increase from the previous average price target of $257.23.
Decoding Analyst Ratings: A Detailed Look
In examining recent analyst actions, we gain insights into how financial experts perceive Ecolab. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Charles Neivert | Piper Sandler | Raises | Overweight | $305.00 | $270.00 |
| Ashish Sabadra | RBC Capital | Raises | Outperform | $306.00 | $260.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $260.00 | $260.00 |
| Joshua Spector | UBS | Lowers | Buy | $276.00 | $288.00 |
| Jason Haas | Wells Fargo | Announces | Overweight | $270.00 | - |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $260.00 | $260.00 |
| Jeffrey Zekauskas | JP Morgan | Raises | Neutral | $228.00 | $225.00 |
| Andrew Wittmann | Baird | Raises | Neutral | $267.00 | $243.00 |
| Patrick Cunningham | Citigroup | Lowers | Buy | $265.00 | $267.00 |
| Steve Byrne | B of A Securities | Raises | Buy | $272.00 | $251.00 |
| Patrick Cunningham | Citigroup | Raises | Neutral | $267.00 | $257.00 |
| Ashish Sabadra | RBC Capital | Maintains | Outperform | $260.00 | $260.00 |
| Joshua Spector | UBS | Raises | Buy | $282.00 | $270.00 |
| Shlomo Rosenbaum | Stifel | Raises | Buy | $283.00 | $233.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Ecolab. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Ecolab compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Ecolab's stock. This comparison reveals trends in analysts' expectations over time.
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Ecolab's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
Stay up to date on Ecolab analyst ratings.
About Ecolab
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.
Understanding the Numbers: Ecolab's Finances
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Ecolab displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 3.47%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Ecolab's net margin excels beyond industry benchmarks, reaching 12.32%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Ecolab's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.95%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.3%, the company showcases effective utilization of assets.
Debt Management: Ecolab's debt-to-equity ratio is below the industry average at 0.98, reflecting a lower dependency on debt financing and a more conservative financial approach.
What Are Analyst Ratings?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
